source
- Menarini secures European rights to Chinese GLP-1 obesity drugMenarini Group, a large family‑owned pharmaceutical company in Italy, has obtained the European commercial rights to a GLP‑1 agonist developed by China’s Gan & Lee. The agreement gives Menarini a…
- Mass General Brigham drops Dana-Farber from its Medicare Advantage network starting Oct 1Mass General Brigham announced that its Medicare Advantage plan will no longer include Dana-Farber Cancer Institute in its provider network beginning October 1, following a recent split between the…